Renovaro Biosciences
RENB
#8801
Rank
S$0.13 B
Marketcap
$0.81
Share price
-4.43%
Change (1 day)
-80.96%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -$2.81

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -$2.72. In 2022 the company made an earnings per share (EPS) of -$2.77 a decrease over its 2021 EPS that were of -$1.06.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.811.39%
2022-$2.77160.76%
2021-$1.06243.48%
2020-$0.3143.75%
2019-$0.22-74.87%
2018-$0.86339.47%
2017-$0.19-48.26%
2016-$0.38-22.22%
2015-$0.487.39%
2014-$0.454351.27%
2013-$0.0101316.6%
2012-$0.008687